Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 26 04 2019
revised: 04 07 2019
accepted: 25 07 2019
pubmed: 21 8 2019
medline: 20 2 2020
entrez: 21 8 2019
Statut: ppublish

Résumé

Obligate anaerobes exist as resident flora in various sites in humans, but they are also emphasized as endogenous causative microorganism of infections. We performed surveillance to understand the trend of drug susceptibility in obligate anaerobic bacteria in the Kinki area of Japan. In the experiment, we used 156 obligate anaerobe isolates collected from 13 institutions that participated in the Study of Bacterial Resistance Kinki Region of Japan. MALDI Biotyper was used to identify the collected strains, and among the 156 test strains, those that could be identified with an accuracy of Score Value 2.0 or more included 6 genera, 30 species, and 144 strains (Bacteroides spp. 77 strains, Parabacteroides sp. 2 strains, Prevotella spp. 29 strains, Fusobacterium spp. 14 strains, Porphyromonas spp. 2 strains, and Clostridioides difficile 20 strains), and they were assigned as subject strains for drug susceptibility testing. The drug susceptibility test was carried out by broth microdilution method using Kyokuto Opt Panel MP ANA (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) and judged according to CLSI criteria. As a result, Bacteroides and Parabacteroides species showed good sensitivities to tazobactam-piperacillin, imipenem, metronidazole and chloramphenicol, and low sensitivities to ampicillin, cefoperazone and vancomycin. Prevotella species showed good sensitivities to sulbactam-ampicillin, tazobactam-piperacillin, cefmetazole, imipenem, doripenem and metronidazole. Susceptibility rates to other drugs were slightly different depending on the bacterial species. Both Fusobacterium spp. and Porphyromonas spp. showed high sensitivities to many drugs. C. difficile was highly sensitive to vancomycin and metronidazole, having MIC

Identifiants

pubmed: 31427200
pii: S1341-321X(19)30229-6
doi: 10.1016/j.jiac.2019.07.018
pii:
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-844

Informations de copyright

Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

Satoshi Shimura (S)

Department of Clinical Laboratory, Otemae Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan. Electronic address: kansenkanri@otemae.gr.jp.

Hideo Watari (H)

Department of Clinical Laboratory, Otemae Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Masaru Komatsu (M)

Department of Clinical Laboratory Science, Tenri Health Care University, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Tomokazu Kuchibiro (T)

Department of Clinical Laboratory, Naga Municipal Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Saori Fukuda (S)

Department of Clinical Pathology, Tenri Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Hisaaki Nishio (H)

Shiga Medical Center for Children, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Machiko Kita (M)

Department of Clinical Laboratory, Japan Community Health Care Organization Shiga Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Kaneyuki Kida (K)

Department of Clinical Laboratory, Japanese Red Cross Otsu Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Masanobu Oohama (M)

Department of Clinical Laboratory, Japanese Red Cross Otsu Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Hirofumi Toda (H)

Department of Clinical Laboratory, Kindai University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Motoi Nishio (M)

Department of Clinical Laboratory, Kindai University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Isao Nishi (I)

Laboratory for Clinical Investigation, Osaka University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Keigo Kimura (K)

Laboratory for Clinical Investigation, Osaka University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Kana Sawa (K)

Department of Clinical Laboratory, Osaka Police Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Nozomi Fukuda (N)

Department of Clinical Laboratory, Osaka Police Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Tomomi Kofuku (T)

Department of Clinical Laboratory, Sumitomo Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Isako Nakai (I)

Department of Clinical Laboratory, Sumitomo Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Makoto Niki (M)

Department of Central Clinical Laboratory, Osaka City University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Tamotsu Ono (T)

Department of Clinical Laboratory, Japanese Red Cross Kyoto Daini Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Tatsuya Nakamura (T)

Faculty of Health Sciences, Kyoto Tachibana University, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Yasunao Wada (Y)

Department of Clinical Laboratory, Hyogo Medical University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH